284 related articles for article (PubMed ID: 33168782)
1. Human mesenchymal stem cells treatment improved hepatic lesions and reversed gut microbiome disorder in non-alcoholic steatohepatitis.
Yang Z; Xia Q; Lu D; Yue H; Zhang J; Li Y; Zhang B; Li X; Cao M
Aging (Albany NY); 2020 Nov; 12(21):21660-21673. PubMed ID: 33168782
[TBL] [Abstract][Full Text] [Related]
2. Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis.
Ye JZ; Li YT; Wu WR; Shi D; Fang DQ; Yang LY; Bian XY; Wu JJ; Wang Q; Jiang XW; Peng CG; Ye WC; Xia PC; Li LJ
World J Gastroenterol; 2018 Jun; 24(23):2468-2481. PubMed ID: 29930468
[TBL] [Abstract][Full Text] [Related]
3. Pure total flavonoids from citrus attenuate non-alcoholic steatohepatitis via regulating the gut microbiota and bile acid metabolism in mice.
He B; Jiang J; Shi Z; Wu L; Yan J; Chen Z; Luo M; Cui D; Xu S; Yan M; Zhang S; Chen Z
Biomed Pharmacother; 2021 Mar; 135():111183. PubMed ID: 33401222
[TBL] [Abstract][Full Text] [Related]
4. Intestinal Microbiota Protects against MCD Diet-Induced Steatohepatitis.
Schneider KM; Mohs A; Kilic K; Candels LS; Elfers C; Bennek E; Schneider LB; Heymann F; Gassler N; Penders J; Trautwein C
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646522
[TBL] [Abstract][Full Text] [Related]
5. Modeling dysbiosis of human NASH in mice: Loss of gut microbiome diversity and overgrowth of Erysipelotrichales.
Carter JK; Bhattacharya D; Borgerding JN; Fiel MI; Faith JJ; Friedman SL
PLoS One; 2021; 16(1):e0244763. PubMed ID: 33395434
[TBL] [Abstract][Full Text] [Related]
6. Mosapride citrate improves nonalcoholic steatohepatitis with increased fecal lactic acid bacteria and plasma glucagon-like peptide-1 level in a rodent model.
Okubo H; Nakatsu Y; Sakoda H; Kushiyama A; Fujishiro M; Fukushima T; Matsunaga Y; Ohno H; Yoneda M; Kamata H; Shinjo T; Iwashita M; Nishimura F; Asano T
Am J Physiol Gastrointest Liver Physiol; 2015 Jan; 308(2):G151-8. PubMed ID: 25428903
[TBL] [Abstract][Full Text] [Related]
7. Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease.
Schwimmer JB; Johnson JS; Angeles JE; Behling C; Belt PH; Borecki I; Bross C; Durelle J; Goyal NP; Hamilton G; Holtz ML; Lavine JE; Mitreva M; Newton KP; Pan A; Simpson PM; Sirlin CB; Sodergren E; Tyagi R; Yates KP; Weinstock GM; Salzman NH
Gastroenterology; 2019 Oct; 157(4):1109-1122. PubMed ID: 31255652
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of puerarin against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis determined by combination of
Gong MJ; Zhu CY; Zou ZJ; Han B; Huang P
J Pharm Biomed Anal; 2021 Apr; 197():113964. PubMed ID: 33601157
[TBL] [Abstract][Full Text] [Related]
9. TMAVA, a Metabolite of Intestinal Microbes, Is Increased in Plasma From Patients With Liver Steatosis, Inhibits γ-Butyrobetaine Hydroxylase, and Exacerbates Fatty Liver in Mice.
Zhao M; Zhao L; Xiong X; He Y; Huang W; Liu Z; Ji L; Pan B; Guo X; Wang L; Cheng S; Xu M; Yang H; Yin Y; Garcia-Barrio MT; Chen YE; Meng X; Zheng L
Gastroenterology; 2020 Jun; 158(8):2266-2281.e27. PubMed ID: 32105727
[TBL] [Abstract][Full Text] [Related]
10. Impact of global PTP1B deficiency on the gut barrier permeability during NASH in mice.
Rubio C; Puerto M; García-Rodríquez JJ; Lu VB; García-Martínez I; Alén R; Sanmartín-Salinas P; Toledo-Lobo MV; Saiz J; Ruperez J; Barbas C; Menchén L; Gribble FM; Reimann F; Guijarro LG; Carrascosa JM; Valverde ÁM
Mol Metab; 2020 May; 35():100954. PubMed ID: 32244182
[TBL] [Abstract][Full Text] [Related]
11. Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites.
Zhu M; Wang X; Wang K; Zhao Z; Dang Y; Ji G; Li F; Zhou W
Front Cell Infect Microbiol; 2023; 13():1066053. PubMed ID: 36779187
[TBL] [Abstract][Full Text] [Related]
12. Mastiha (Pistacia lentiscus) Improves Gut Microbiota Diversity, Hepatic Steatosis, and Disease Activity in a Biopsy-Confirmed Mouse Model of Advanced Non-Alcoholic Steatohepatitis and Fibrosis.
Kannt A; Papada E; Kammermeier C; D'Auria G; Jiménez-Hernández N; Stephan M; Schwahn U; Madsen AN; Østergaard MV; Dedoussis G; Francino MP;
Mol Nutr Food Res; 2019 Dec; 63(24):e1900927. PubMed ID: 31599067
[TBL] [Abstract][Full Text] [Related]
13. Altered Gut Microbiota Composition and Immune Response in Experimental Steatohepatitis Mouse Models.
Ishioka M; Miura K; Minami S; Shimura Y; Ohnishi H
Dig Dis Sci; 2017 Feb; 62(2):396-406. PubMed ID: 27913996
[TBL] [Abstract][Full Text] [Related]
14. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development.
Mouries J; Brescia P; Silvestri A; Spadoni I; Sorribas M; Wiest R; Mileti E; Galbiati M; Invernizzi P; Adorini L; Penna G; Rescigno M
J Hepatol; 2019 Dec; 71(6):1216-1228. PubMed ID: 31419514
[TBL] [Abstract][Full Text] [Related]
15. Butyrate Protects Mice Against Methionine-Choline-Deficient Diet-Induced Non-alcoholic Steatohepatitis by Improving Gut Barrier Function, Attenuating Inflammation and Reducing Endotoxin Levels.
Ye J; Lv L; Wu W; Li Y; Shi D; Fang D; Guo F; Jiang H; Yan R; Ye W; Li L
Front Microbiol; 2018; 9():1967. PubMed ID: 30186272
[TBL] [Abstract][Full Text] [Related]
16. [Intestinal flora polymorphisms with different lesional stages in an animal model of MAFLD].
Xia QY; Lu D; Zhang JM; Wei YC; Yang MM; Yang ZY; Cao MB
Zhonghua Gan Zang Bing Za Zhi; 2021 Nov; 29(11):1069-1076. PubMed ID: 34933425
[No Abstract] [Full Text] [Related]
17. Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease.
Machado MV; Michelotti GA; Xie G; Almeida Pereira T; Boursier J; Bohnic B; Guy CD; Diehl AM
PLoS One; 2015; 10(5):e0127991. PubMed ID: 26017539
[TBL] [Abstract][Full Text] [Related]
18. Human umbilical cord mesenchymal stromal cell-derived exosomes protect against MCD-induced NASH in a mouse model.
Shi Y; Yang X; Wang S; Wu Y; Zheng L; Tang Y; Gao Y; Niu J
Stem Cell Res Ther; 2022 Nov; 13(1):517. PubMed ID: 36371344
[TBL] [Abstract][Full Text] [Related]
19. Aqueous extract of Polygala japonica Houtt. ameliorated nonalcoholic steatohepatitis in mice through restoring the gut microbiota disorders and affecting the metabolites in feces and liver.
Liao J; Cao Y; Zhao J; Yu B; Wang Y; Li W; Li H; Lv S; Wen W; Cui H; Chen Y
Phytomedicine; 2023 Sep; 118():154937. PubMed ID: 37393831
[TBL] [Abstract][Full Text] [Related]
20. [Mechanism of Tibetan medicine Ershiwuwei Songshi Pills in regulating intestinal flora and improving non-alcoholic steatohepatitis].
Jian CF; Zhang BY; Wang CP; Sha YR; Li AR; Gong PY; Gu J; Tan R
Zhongguo Zhong Yao Za Zhi; 2022 Apr; 47(8):2038-2048. PubMed ID: 35531719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]